Source:http://linkedlifedata.com/resource/pubmed/id/15851850
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-4-26
|
pubmed:abstractText |
Biomarkers to assist in the diagnosis and medical management of Alzheimer disease (AD) are a pressing need. We have employed a proteomic approach, microcapillary liquid chromatography mass spectrometry of proteins labeled with isotope-coded affinity tags (ICAT), to quantify relative changes in the proteome of human cerebrospinal fluid (CSF) obtained from the lumbar cistern. Using CSF from well-characterized AD patients and age-matched controls at 2 different institutions, we quantified protein concentration ratios of 42% of the 390 CSF proteins that we have identified and found differences > or = 20% in over half of them. We confirmed our findings by western blot and validated this approach by quantifying relative levels of amyloid precursor protein and cathepsin B in 17 AD patients and 16 control individuals. Quantitative proteomics of CSF from AD patients compared to age-matched controls, as well as from other neurodegenerative diseases, will allow us to generate a roster of proteins that may serve as specific biomarker panels for AD and other geriatric dementias.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1387-2877
|
pubmed:author |
pubmed-author:AebersoldRuedi HRH,
pubmed-author:EngJimmyJ,
pubmed-author:GoodlettDave RDR,
pubmed-author:KayeJeffrey AJA,
pubmed-author:MontineThomas JTJ,
pubmed-author:PanCatherineC,
pubmed-author:PeskindElaineE,
pubmed-author:QuinnJoseph FJF,
pubmed-author:WangQinQ,
pubmed-author:YiEugeneE,
pubmed-author:ZhangJingJ,
pubmed-author:ZhouYongY
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-33; discussion 173-80
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15851850-Adult,
pubmed-meshheading:15851850-Alzheimer Disease,
pubmed-meshheading:15851850-Biological Markers,
pubmed-meshheading:15851850-Blotting, Western,
pubmed-meshheading:15851850-Cell Fractionation,
pubmed-meshheading:15851850-Female,
pubmed-meshheading:15851850-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:15851850-Humans,
pubmed-meshheading:15851850-Male,
pubmed-meshheading:15851850-Middle Aged,
pubmed-meshheading:15851850-Proteome,
pubmed-meshheading:15851850-Proteomics
|
pubmed:year |
2005
|
pubmed:articleTitle |
Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.
|
pubmed:affiliation |
Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|